Lack of association between IL-1β, TNF-α, and IL-10 gene polymorphisms and sporadic Parkinson’s disease in an Italian cohort

scientific article published on September 29, 2010

Lack of association between IL-1β, TNF-α, and IL-10 gene polymorphisms and sporadic Parkinson’s disease in an Italian cohort is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1600-0404.2010.01441.X
P953full work available at URLhttp://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0404.2010.01441.x/fullpdf
https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1600-0404.2010.01441.x
P698PubMed publication ID20880267

P50authorAnnarita VestriQ92258401
P2093author name stringG. Meco
E. Pascale
R. Guglielmi
F. Passarelli
E. Passarelli
C. Purcaro
A. Fakeri
P2860cites workA simple salting out procedure for extracting DNA from human nucleated cellsQ27861086
Association between IL-1beta -511C/T and IL-1RA (86bp)n repeats polymorphisms and schizophreniaQ28210488
Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanismQ29615446
Pathogenic role of glial cells in Parkinson's disease.Q35050071
Inflammation, the complement system and the diseases of agingQ36273979
Tumor necrosis factor-alpha mediated signaling in neuronal homeostasis and dysfunctionQ37680121
Frequency of cytokine polymorphisms in populations from western Europe, Africa, Asia, the Middle East and South AmericaQ39240429
The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription.Q41117030
Inflammation, genetics, and longevity: further studies on the protective effects in men of IL-10 -1082 promoter SNP and its interaction with TNF-alpha -308 promoter SNP.Q43074184
Association of an interleukin 1B gene polymorphism (-511) with Parkinson's disease in Finnish patientsQ43074720
Functional promoter region polymorphism of the proinflammatory chemokine IL-8 gene associates with Parkinson's disease in the IrishQ44878101
Inflammatory cytokine gene polymorphisms and increased risk of Parkinson diseaseQ46072995
Glutathione-S-transferase-1 and interleukin-1beta gene polymorphisms in Japanese patients with Parkinson's disease.Q46441171
Serum heme oxygenase-1 levels are increased in Parkinson's disease but not in Alzheimer's diseaseQ48448186
Polymorphisms in the interleukin-1 alpha and beta genes and the risk for Parkinson's diseaseQ48586505
Association of interleukin-1 beta polymorphisms with idiopathic Parkinson's diseaseQ48586511
Lack of association between TNF-alpha polymorphisms and Alzheimer's disease in an Italian cohortQ48894523
Investigation of genes coding for inflammatory components in Parkinson's diseaseQ49152293
Inflammation-related genes and the risk of Parkinson's disease: a multilocus approach.Q50658807
Tumor necrosis factor alpha gene G-308A polymorphism, insulin resistance, and fasting plasma glucose in young, older, and diabetic Japanese men.Q51551763
Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients.Q53213249
Interleukin-10 promoter polymorphism in sporadic Alzheimer's disease.Q53357994
Circulating interleukin-10 and interleukin-12 in Parkinson's disease.Q54682442
Tumor necrosis factor-α−308A/G polymorphism is associated with age at onset of Alzheimer's diseaseQ60442029
Genetic analysis of immunomodulating factors in sporadic Parkinson's diseaseQ60689245
Allele frequencies of polymorphisms of TNFA, IL-6, IL-10 and IFNG in an Italian Caucasian populationQ60748340
Interleukin-10 Gene Polymorphism in Parkinson's Disease PatientsQ61945779
Interleukin-10 (IL10) and tumor necrosis factor α (TNF) gene polymorphisms in Parkinson's disease patientsQ62588917
Influence of interleukin-1beta gene polymorphisms on age-at-onset of sporadic Parkinson's diseaseQ64786053
Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from parkinsonian patientsQ72119481
Tumor necrosis factor gene polymorphisms in patients with sporadic Parkinson's diseaseQ74590742
Tumor necrosis factor-alpha promoter polymorphism is associated with the risk of Parkinson's diseaseQ79456999
P433issue3
P407language of work or nameEnglishQ1860
P921main subjectParkinson's diseaseQ11085
P304page(s)176-181
P577publication date2010-09-29
P1433published inActa Neurologica ScandinavicaQ4676732
P1476titleLack of association between IL-1β, TNF-α, and IL-10 gene polymorphisms and sporadic Parkinson's disease in an Italian cohort
Lack of association between IL-1β, TNF-α, and IL-10 gene polymorphisms and sporadic Parkinson’s disease in an Italian cohort
P478volume124

Reverse relations

cites work (P2860)
Q33932167Association of NQO1 and TNF polymorphisms with Parkinson's disease: A meta-analysis of 15 genetic association studies
Q49197356From Genomics to Omics Landscapes of Parkinson's Disease: Revealing the Molecular Mechanisms
Q38103856Interleukin-1β and tumor necrosis factor-α: reliable targets for protective therapies in Parkinson's Disease?
Q35737149Interleukin-1β in Central Nervous System Injury and Repair.
Q46926746Let's make microglia great again in neurodegenerative disorders.
Q38148491Neurodegeneration in Parkinson's disease: interactions of oxidative stress, tryptophan catabolites and depression with mitochondria and sirtuins
Q27027973Neuroimmunological processes in Parkinson's disease and their relation to α-synuclein: microglia as the referee between neuronal processes and peripheral immunity
Q35510197Role of α-synuclein in inducing innate and adaptive immunity in Parkinson disease.
Q37485007The therapeutic potential of interleukin-10 in neuroimmune diseases.